EN
HI

Parmax Pharma Share price

PARMAX

HealthcareSmall

3940

3900.60 (9900.00%)
Last updated on 1 Jul, 2025 | 09:32 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

29.00

52 Week High

55.02

The current prices are delayed, login to your account for live prices

Parmax Pharma Chart

Parmax Pharma Share Key Metrics

Volume
0.00
Market Cap
14.74 CR
LTQ@LTP
0@39.40
ATP
0
Var Margin
34.42 %
Circuit Range
31.52-47.28
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1

Parmax Pharma Futures & Options

Data Not Found

Parmax Pharma Corporate Actions

DateAgenda
2025-05-30Audited Results
2025-02-14Quarterly Results
DateEvent TypeAgenda
2025-05-30Board MeetingAudited Results
2025-02-14Board MeetingQuarterly Results

Parmax Pharma News

No Data Found

About Parmax Pharma

NSE : 0  
BSE : 540359  
ISIN : INE240T01014  

Parmax Pharma Limited was incorporated as a public limitedcompany on 02-11-1994 and the company received theCertificate of commencement of business from the Registrarof Companies Gujarat on 10-3-95. The Company is planningto set up a bulk drug plant to manufacture Amoxycillin trihydrade ampicillin tri hydrade Cephalexin mono hydrateand Nalidixic acid at Hadamtala Gondal. Dist Rajkot.

Parmax Pharma Management

NamePosition
Dr. Umang Alkesh Gosalia Managing Director
Ms. Ami R Shah Independent Director
Mr. Nikhil S Uchat Independent Director
Read More

Parmax Pharma FAQs

The Buying Price of Parmax Pharma share is 3940 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Parmax Pharma share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 29.54 & 3.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Parmax Pharma is 14.74 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Parmax Pharma share price is 55.02 & 29.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.